Skip to main content

Table 4 Multivariate linear regression for change in EQ-5D VAS score

From: Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study

Variables

Coefficient

P-value

Intercept

5.4377

0.1041

Macro-complications (yes = 1, no = 0)

-0.6064

0.3188

Micro-complications (yes = 1, no = 0)

1.4226

0.0067

Duration of diabetes

0.02993

0.5239

Age

0.02403

0.2699

Male

-0.839

0.0944

BMI at baseline

-0.1454

0.0554

Pre_study treatment (Insulin naïve = 1, insulin users = 0)

-0.5474

0.3547

HbA1c at baseline

0.3459

0.0013

SBP at baseline

0.0208

0.1661

Total cholesterol at baseline

0.4528

0.0817

HDL at baseline

-2.3537

<.001

LDL at baseline

-0.7543

0.0138

Total hypoglycaemia at baseline (yes = 1, no = 0)

0.01457

0.9628

Major hypoglycaemia at baseline (yes = 1, no = 0)

6.957

<.001